IDN 5370
Alternative Names: CGP 82630Latest Information Update: 27 Nov 2007
At a glance
- Originator Idun Pharmaceuticals
- Class Small molecules
- Mechanism of Action Caspase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 16 Dec 2003 No development reported - Preclinical for Neurological disorders (Prevention) in USA (unspecified route)
- 02 Feb 2001 IDN 5370 is available for licensing (http://www.idun.com)
- 22 Nov 2000 Preclinical development for Neurological disorders (Prevention) in USA (Unknown route)